KalVista Pharmaceuticals Acquired by Chiesi Farmaceutici | Healthcare M&A Deal

Chiesi Farmaceutici has agreed to acquire KalVista Pharmaceuticals, a pharmacy business in Delaware, for $27.00 per share in cash, net to the seller, as part of a going private acquisition. KalVista Pharmaceuticals develops and commercializes specialty medicines, supporting Chiesi Farmaceutici acquisitions in the healthcare M&A market. The pharmacy acquisition is structured through Skyline Merger Sub, Inc., a wholly owned subsidiary of Chiesi Farmaceutici S.p.A., with the tender offer governed under U.S. SEC Schedule TO. The strategic acquisition is announced as a cross-border going private acquisition, with an amendment filed as part of the tender offer process and an over $100M deal size disclosed.